Health Care

Commentary

Despite Dems’ protests, affordable health plans are about to multiply

Obamacare premiums are climbing yet again during open enrollment. But there’s also some good news for cost-conscious shoppers ― a new way to secure affordable coverage without forgoing access to care. This year, many people can buy low-cost “catastrophic” health plans for the very first time. Combine one of these ...
Commentary

How Competition Drives Healthcare Innovation & Affordability

Making healthcare more affordable requires reforms that strengthen competitive markets, as I outlined in a recent Pacific Research Institute1 paper. Unfortunately, as we’re seeing in California and elsewhere, the trend in government is away from competition and toward fewer choices, hurting patients and increasing costs. When applied to other industries, ...
Blog

How did the US become the world’s center of pharmaceutical innovation?

What kinds of policies helped the US surpass Great Britain to become the world’s center of pharmaceutical innovation? I think it was a combination of shrewd reforms on the part of the United States, and self-destructive reforms on the part of Europe and other developed nations. In the 1970s, Europe ...
Commentary

Trade Policy Is The Right Way To Fight Foreign Freeloading

Last week, the United States and the United Kingdom announced a trade deal that will require Britain’s National Health Service to pay more for novel prescription drugs in exchange for a reprieve of at least three years from tariffs on its pharmaceutical exports. It’s a perfect example of how the ...
Commentary

‘Soak the Rich’ Won’t Rescue Calif. Healthcare

A group of unions in California has proposed a new plan for paying for healthcare — soak the rich. That’s the idea behind the Billionaire Tax Act, a 2026 ballot initiative that would impose a 5% tax on the state’s billionaires in order to raise money for healthcare programs and ...
Health Care

Sally Pipes – On the Health Care Debate in Washington

This week, PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy Sally Pipes is back to discuss the debate over extending the expanded Obamacare subsidies that was at the heart of the recent government shutdown.  She also discusses the market-based reforms that conservatives in Congress should be ...
Commentary

Competition, not price controls, just slashed GLP-1 prices

Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 a month. Patients buying directly from the manufacturer will be able to pay as little as $349 for a monthly dose of these medicines. The company has also dropped ...
Commentary

From Obamacare To Credit Cards, Price Controls Don’t Work

The House of Representatives just passed a resolution condemning the “horrors of socialism” by a 285 to 98 margin. All the no votes were cast by Democrats indicating that a majority of the members from the left side of the aisle fail to recognize socialism’s overwhelming failures. Thus, despite the ...
Commentary

A Healthy Dose Of Competition Sends Weight-Loss Drug Prices Plummeting

Prices for GLP-1 weight-loss medications are dropping fast. Last week, Novo Nordisk—maker of Ozempic and Wegovy—announced it would cut prices for monthly supplies of both drugs to as low as $349 for existing patients buying directly. For new customers, the price will fall to just $199 a month for the ...
Commentary

Trump got shots because he knows vaccines work

The cold and flu and COVID season is here. Millions of Americans are weighing when and whether to get their shots. It’s an appropriate time to reflect on the power of vaccination and how many lives new shots have saved in recent years. As Senators Bill Cassidy and John Barrasso ...
Commentary

Despite Dems’ protests, affordable health plans are about to multiply

Obamacare premiums are climbing yet again during open enrollment. But there’s also some good news for cost-conscious shoppers ― a new way to secure affordable coverage without forgoing access to care. This year, many people can buy low-cost “catastrophic” health plans for the very first time. Combine one of these ...
Commentary

How Competition Drives Healthcare Innovation & Affordability

Making healthcare more affordable requires reforms that strengthen competitive markets, as I outlined in a recent Pacific Research Institute1 paper. Unfortunately, as we’re seeing in California and elsewhere, the trend in government is away from competition and toward fewer choices, hurting patients and increasing costs. When applied to other industries, ...
Blog

How did the US become the world’s center of pharmaceutical innovation?

What kinds of policies helped the US surpass Great Britain to become the world’s center of pharmaceutical innovation? I think it was a combination of shrewd reforms on the part of the United States, and self-destructive reforms on the part of Europe and other developed nations. In the 1970s, Europe ...
Commentary

Trade Policy Is The Right Way To Fight Foreign Freeloading

Last week, the United States and the United Kingdom announced a trade deal that will require Britain’s National Health Service to pay more for novel prescription drugs in exchange for a reprieve of at least three years from tariffs on its pharmaceutical exports. It’s a perfect example of how the ...
Commentary

‘Soak the Rich’ Won’t Rescue Calif. Healthcare

A group of unions in California has proposed a new plan for paying for healthcare — soak the rich. That’s the idea behind the Billionaire Tax Act, a 2026 ballot initiative that would impose a 5% tax on the state’s billionaires in order to raise money for healthcare programs and ...
Health Care

Sally Pipes – On the Health Care Debate in Washington

This week, PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy Sally Pipes is back to discuss the debate over extending the expanded Obamacare subsidies that was at the heart of the recent government shutdown.  She also discusses the market-based reforms that conservatives in Congress should be ...
Commentary

Competition, not price controls, just slashed GLP-1 prices

Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 a month. Patients buying directly from the manufacturer will be able to pay as little as $349 for a monthly dose of these medicines. The company has also dropped ...
Commentary

From Obamacare To Credit Cards, Price Controls Don’t Work

The House of Representatives just passed a resolution condemning the “horrors of socialism” by a 285 to 98 margin. All the no votes were cast by Democrats indicating that a majority of the members from the left side of the aisle fail to recognize socialism’s overwhelming failures. Thus, despite the ...
Commentary

A Healthy Dose Of Competition Sends Weight-Loss Drug Prices Plummeting

Prices for GLP-1 weight-loss medications are dropping fast. Last week, Novo Nordisk—maker of Ozempic and Wegovy—announced it would cut prices for monthly supplies of both drugs to as low as $349 for existing patients buying directly. For new customers, the price will fall to just $199 a month for the ...
Commentary

Trump got shots because he knows vaccines work

The cold and flu and COVID season is here. Millions of Americans are weighing when and whether to get their shots. It’s an appropriate time to reflect on the power of vaccination and how many lives new shots have saved in recent years. As Senators Bill Cassidy and John Barrasso ...
Scroll to Top